By: Chris Coburn

Tags: research and discovery , industry interactions

WMIF logo

Throughout the United States, every phase of healthcare is being fundamentally restructured. As these changes take place, the need for disruptive research and applied innovation will remain an enduring priority. Partners HealthCare, as the largest single academic research entity, is convening leaders from around the globe to consider the future of collaborative innovation as part of the inaugural World Medical Innovation Forum.

The event, an international gathering of more than 1,000 senior decision-makers from the life sciences, investment, clinical, entrepreneurial and academic communities, will be taking place in Boston from April 27-29, 2015. The Forum is rooted in the belief that no matter how greatly the health care industry transforms, health care providers remain committed to working together to improve patient lives through innovation.

The focus for this first World Forum will be the neurosciences. The Forum will present an unprecedented opportunity for senior executives, investors, entrepreneurs, physicians and scientists on the forefront of medical advancement to discuss the most compelling advances in neuroscience technology, care and research, as well as the importance of innovation throughout health care.

Keynote speakers will include CEOs from some of the most important companies in the neurosciences and healthcare in general, such as General Electric, Aetna, Amgen, Biogen Idec, Boston Scientific, Genzyme, Vertex Pharmaceuticals and many more. Also keynoting the Forum are dozens of internationally recognized Partners’ leaders and Harvard Medical School Faculty such as Atul Gawande, M.D., and Rudy Tanzi, Ph.D.

More than 100 expert speakers will discuss advances and unmet needs in areas such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, depression, schizophrenia, autism, stroke and sleep disorders. The Forum will also highlight new tools and interventions in genome editing, gene therapy, neurostimulation, neurodegeneration, population management, neuroimaging and neurological biomarkers.

In addition to examining the cutting-edge issues in the field, the Forum will feature the “Disruptive Dozen” – 12 emerging technologies with the potential to revolutionize the neurosciences over the next decade.

Through its unprecedented roster of presenters and top attendees, the hope is that meaningful engagement throughout the World Forum will spark the new partnerships needed to address longstanding unmet needs and lay the groundwork for future collaborations.

For more information or to register, please visit the Forum website.